Literature DB >> 8481068

'Subclinical hypothyroidism'. Natural course of the syndrome during a prolonged follow-up study.

U M Kabadi1.   

Abstract

OBJECTIVE: To determine the natural course of the syndrome "subclinical hypothyroidism."
DESIGN: Prospective study of 30 subjects with "subclinical hypothyroidism," as documented precisely by normal serum thyroxine and triiodothyronine concentrations and high serum thyrotropin levels on three occasions at intervals of 2 to 3 weeks. The subjects were followed up for 4 to 15 years (mean, 8.2 +/- 2.3 years), with repeated determinations of thyroid hormone indices at intervals of 3 to 6 months.
SETTING: Endocrinology Clinic at the Veterans Affairs Medical Center.
RESULTS: 16 subjects developed definitive primary hypothyroidism within 3 months to 2 years, as reflected by a progressive rise in serum thyrotropin level with a gradual decline in serum thyroxine and triiodothyronine concentrations, with serum thyroxine levels falling to subnormal concentrations. In 14 of these subjects, primary hypothyroidism could be attributed to known etiologic factors, whereas in the remaining two the cause was not apparent. Persistently elevated serum thyrotropin with normal serum thyroxine and triiodothyronine concentrations following a cyclic pattern was observed in 14 subjects during the follow-up period. In 11 of these subjects, there was a history of non-radical surgery or conventional radiation therapy to the neck area, whereas in the remaining three subjects, no apparent cause could be identified.
CONCLUSIONS: "Subclinical hypothyroidism" is not always a forerunner of primary hypothyroidism. Two distinct populations evolve: (1) those with true preclinical or subclinical hypothyroidism, which may be predicted by the presence of one of the well-known etiologic factors responsible for onset of primary hypothyroidism, and (2) euthyroidism with reset thyrostat--a permanent state without a definitive progression to hypothyroidism, most probably secondary to a previous subtle insult to the thyroid gland.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8481068     DOI: 10.1001/archinte.153.8.957

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  24 in total

1.  Variants near FOXE1 are associated with hypothyroidism and other thyroid conditions: using electronic medical records for genome- and phenome-wide studies.

Authors:  Joshua C Denny; Dana C Crawford; Marylyn D Ritchie; Suzette J Bielinski; Melissa A Basford; Yuki Bradford; High Seng Chai; Lisa Bastarache; Rebecca Zuvich; Peggy Peissig; David Carrell; Andrea H Ramirez; Jyotishman Pathak; Russell A Wilke; Luke Rasmussen; Xiaoming Wang; Jennifer A Pacheco; Abel N Kho; M Geoffrey Hayes; Noah Weston; Martha Matsumoto; Peter A Kopp; Katherine M Newton; Gail P Jarvik; Rongling Li; Teri A Manolio; Iftikhar J Kullo; Christopher G Chute; Rex L Chisholm; Eric B Larson; Catherine A McCarty; Daniel R Masys; Dan M Roden; Mariza de Andrade
Journal:  Am J Hum Genet       Date:  2011-10-07       Impact factor: 11.025

2.  Normal thyroxine and elevated thyrotropin concentrations: evolving hypothyroidism or persistent euthyroidism with reset thyrostat.

Authors:  U M Kabadi; R Cech
Journal:  J Endocrinol Invest       Date:  1997-06       Impact factor: 4.256

Review 3.  The debate on treating subclinical hypothyroidism.

Authors:  Eng Loon Tng
Journal:  Singapore Med J       Date:  2016-10       Impact factor: 1.858

4.  Phosphorous magnetic resonance spectroscopy-based skeletal muscle bioenergetic studies in subclinical hypothyroidism.

Authors:  P Rana; G Sripathy; A Varshney; P Kumar; M Memita Devi; R K Marwaha; R P Tripathi; S Khushu
Journal:  J Endocrinol Invest       Date:  2011-04-20       Impact factor: 4.256

Review 5.  The TSH upper reference limit: where are we at?

Authors:  Peter Laurberg; Stig Andersen; Allan Carlé; Jesper Karmisholt; Nils Knudsen; Inge Bülow Pedersen
Journal:  Nat Rev Endocrinol       Date:  2011-02-08       Impact factor: 43.330

6.  Urinary cortisol metabolites in the assessment of peripheral thyroid hormone action: overt and subclinical hypothyroidism.

Authors:  M C Vantyghem; A Ghulam; C Hober; C Schoonberg; M D'Herbomez; A Racadot; A Boersma; J Lefebvre
Journal:  J Endocrinol Invest       Date:  1998-04       Impact factor: 4.256

Review 7.  Subclinical hypothyroidism: the state of the art.

Authors:  T Arrigo; M Wasniewska; G Crisafulli; F Lombardo; M F Messina; I Rulli; G Salzano; M Valenzise; G Zirilli; F De Luca
Journal:  J Endocrinol Invest       Date:  2008-01       Impact factor: 4.256

Review 8.  Clinical use of sensitive assays for thyroid-stimulating hormone.

Authors:  P A Masters; R J Simons
Journal:  J Gen Intern Med       Date:  1996-02       Impact factor: 5.128

9.  Prospective observation of 5-year clinical course of subclinical hypothyroidism in korean population.

Authors:  Woo Ri Park; Tae Keun Oh; Hyun Jeong Jeon
Journal:  J Korean Med Sci       Date:  2013-10-31       Impact factor: 2.153

Review 10.  Subclinical thyroid disease.

Authors:  J W Elte; A H Mudde; A C Nieuwenhuijzen Kruseman
Journal:  Postgrad Med J       Date:  1996-03       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.